Prevalence Of Periodontitis Stage III & IV

July 13, 2020 updated by: Omar Khaled Gamil Moussa Megahed, Cairo University

Prevalence Of Periodontitis Stage III &IV: A Hospital-Based Cross-Sectional Study On A Sample Of Adult Egyptian Dental Patients

The study is a cross-sectional survey investigating the prevalence of Periodontitis stage III & IV in Egyptian dental patients attending the oral diagnosis clinic at faculty of Dentistry, Cairo University

Study Overview

Status

Completed

Conditions

Detailed Description

Since the 1999 workshop, substantial new information has emergedfrom population studies, basic science investigations, and evidencefrom prospective studies evaluating environmental and systemic riskfactors. The analysis of this evidence has prompted the 2017 workshopto develop a new classification framework for periodontitis

In the last 30 years, the classification of periodontitis has been repeatedly upgraded in an attempt to align it with emerging scientific evidence. The workshop agreed that, consistent with current knowledge on pathophysiology, three forms of periodontitis can be identified: necrotizing periodontitis, periodontitis as a manifestation of systemic disease and the forms of the disease previously known as "chronic" or "aggressive", now grouped under a single category, "periodontitis".In revising the classification, the workshop agreed on a classification framework for periodontitis further characterized based on a multidimensional staging and grading system that could be adapted over time as new evidence emerges

Staging is largely dependent upon the severity of disease at presentationas well as on the complexity of disease management.While,grading provides supplemental information about biological features of the disease, including a history based analysis of the rate of disease progression, assessment of the risk for further progression, anticipated poor outcomes of treatment, and assessment of the risk that the disease or its treatment may negatively affect the general health of the patient

Staging involves four categories (stages 1 through 4) and is determined after considering several variables including clinical attachment loss, amount and percentage of bone loss, probing depth, presence and extent of angular bony defects, furcation involvement,tooth mobility and tooth loss due to periodontitis.

Stage III & IV are characterized by interdental clinical attatchment loss > 5mm and radiographic bone loss extending to the middle or apical third of the root. In stage III, four teeth or less are lost while in stage IV, five teeth or more are lost due to periodontitis. In addition to stage II complexity, Stage III is characterized by probing depth greater than or equal 6 mm, vertical bone loss greater than or equal 3mm, furcation involvement class II or III and moderate ridge defect. In addition to stage III complexity, stage IV is characterized by severe ridge defect , bite collapse, drifting and flaring.

The study aims at determining the prevalence of Periodontitis Stage III & IV in adult Egyptian dental outpatients attending the diagnostic centre at faculty of Dentistry, Cairo University

Study Type

Observational

Enrollment (Actual)

750

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Faculty of dentistry , Cairo Univeristy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

  • Dental patients will be recruited in a consecutive manner from the outpatient Diagnostic center, Faculty of Dentistry, Cairo University.
  • Medical history will be taken, thorough oral examination will be done, and a full questionnaire will be filled for each patient.
  • Before filling the questionnaire, the aim of the study will be explained to the patient and the patient's acceptance to participate in the survey will be received.
  • Non-respondent patients or patients refusing to participate will be reported with the cause of their refusal.
  • The questionnaire will be filled through a face-to-face personal interview with the patient using simple, short, easily comprehended questions.
  • The Questionnaire will include a section for demographic information of age, sex, social and educational levels of the patient. It will also include questions about medical condition, habits of trauma, smoking and its frequency.

Description

Inclusion Criteria:

  • Patients whose age is above 15 years old.
  • Patient consulting in the outpatient clinic
  • Provide informed consent.

Exclusion Criteria:

  • Patients having problem in opening their mouth or undergoing intermaxillary fixation where oral examination will not be possible.
  • Patients diagnosed with psychiatric problems or intoxicated with alcohol or drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
prevalence of Periodontitis stage III & IV
Time Frame: after recriutment of required sample size , through study completion an average of one year
after recriutment of required sample size , through study completion an average of one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2019

Primary Completion (Actual)

June 15, 2019

Study Completion (Actual)

September 15, 2019

Study Registration Dates

First Submitted

December 15, 2018

First Submitted That Met QC Criteria

December 18, 2018

First Posted (Actual)

December 19, 2018

Study Record Updates

Last Update Posted (Actual)

July 15, 2020

Last Update Submitted That Met QC Criteria

July 13, 2020

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 21252461

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

3
Subscribe